Table 1.
Investigation of miscellaneous amide analogues.
![]() | ||||
---|---|---|---|---|
R | hSUCNR1 | mSUCNR1 | ClogPb | |
pEC50 (efficacy, %)a | ||||
3 |
![]() |
5.75 ± 0.08 (72.8 ± 2.6) | 6.46 ± 0.06 (79.3 ± 1.6) | 1.66 |
4 |
![]() |
4.53 ± 0.13 (78.1 ± 7.5) | 4.93 ± 0.05 (95.8 ± 2.9) | 0.44 |
5 |
![]() |
22% @10−4M | 13% @10−4M | 0.28 |
6 |
![]() |
50% @10−4M | 64% @10−4M | 1.52 |
7 |
![]() |
8% @10−4M | 15% @10−4M | 1.26 |
8 |
![]() |
5% @10−4M | 11% @10−4M | 1.28 |
9 |
![]() |
25% @10−4M | 15% @10−4M | 2.44 |
apEC50 values were determined from dose-response curves of induction of IP3 turnover in SUCNR1 transfected HEK cells (N = 3), efficacy is determined relative to succinate (100%). bCalculated by BioByte’s algorithm as implemented in ChemDraw Professional 16.0.1.4 (ClogP option).